NexSig Neurological Examination Technologies

NexSig Neurological Examination Technologies was an Israeli digital health company that developed software-based diagnostic solutions for the early detection of neurological disorders. Its core product, NexAde, was a self-administered computerized test that analyzed biometric signals and computer interaction patterns to assess cognitive state. The technology aimed to identify patients at risk for conditions such as Alzheimer's disease and dementia by measuring subtle changes in motor and cognitive performance using standard computer peripherals as sensors. Founded in 2004 and based in Kiryat Gat, the company reached the initial revenue stage before ceasing operations in early 2012.